CDXS(Codexis, Inc.) · 财务报表

CDXS(Codexis, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$104.75M$138.59M$70.14M$59.34M$70.39M
毛利润$82.55M$100.56M$57.33M$43.06M$61.05M
营业利润−$22.70M−$34.88M−$68.07M−$58.52M−$41.74M
净利润−$21.28M−$33.59M−$76.24M−$65.28M−$43.97M
经营现金流−$14.27M$11.28M−$52.64M−$49.41M−$19.38M
自由现金流−$28.09M$2.98M−$57.06M−$53.72M−$23.85M
摊薄每股收益$-0.33$-0.51$-1.12$-0.89$-0.50

Codexis, Inc. CDXS